What Happened? Shares of healthcare data analytics company Health Catalyst (NASDAQ:HCAT) fell 23.1% in the afternoon session after the company provided a wea...
Health Catalyst (NASDAQ:HCAT) reported second-quarter 2026 revenue above the high end of its guidance range and adjusted EBITDA at the high end of its outlook, while outlining a strategic shift following the July 31 divestiture of its Vitalware and Med-Metrix businesses.
Chief Executive Officer Ben
Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 12.7%...
Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) will be reporting earnings this Thursday after the bell. Here’s what to expect. Health Cataly...
What Happened? A number of stocks jumped in the afternoon session after the software sector caught a massive tailwind, fueled by easing geopolitical tensions...
What Happened? A number of stocks fell in the afternoon session after sentiment continued to weaken as tech stocks faced a dual headwind of deteriorating mac...
Health Catalyst (NASDAQ:HCAT) stockholders approved three of four proposals presented at the company’s 2026 annual meeting, including the election of two directors, ratification of the company’s auditor and an advisory vote on executive compensation. A proposal to phase out the company’s classified
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Health Catalyst has been treading water for the past six months, recording a small loss of 3.6% while holding steady at $2.26. The stock also fell short of t...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
What Happened? A number of stocks fell in the afternoon session after President Trump declared the Iran ceasefire "over" and threatened renewed strikes, send...
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re barga...
What Happened? A number of stocks jumped in the afternoon session after Guggenheim's John DiFucci upgraded both Salesforce and ServiceNow to Buy, arguing the...
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HC...
What Happened? A number of stocks fell in the afternoon session after a confluence of high-profile AI talent departures from Alphabet, and a regulatory overh...
Software is rapidly reducing operating expenses for businesses. This secular theme makes SaaS companies attractive investment candidates but also comes with ...
What Happened? A number of stocks fell in the afternoon session as investors rotated from the high-multiple growth names that led the recent rally. Software ...
What Happened? A number of stocks fell in the afternoon session after Anthropic released new models (Claude Fable 5 and Claude Mythos 5) which were described...
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
